$29.66
-1.83 (-5.81%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+183.1% upside
Low Target
$51.90
Average Target
$83.97
High Target
$108.57
Current Price
$29.66
Current
$29.66
$29.66
Target
$83.97
$83.97
$51.90
$83.97 avg
$108.57
Scenario Analysis
Bear Case
$51.90
75.0%
Low target
Base Case
$83.97
+183.1%
Avg target
Bull Case
$108.57
+266.0%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$43.73
-32.2% from high
52-Week Low
$13.78
+115.2% from low
50-Day SMA
$32.08
-7.5% vs SMA
200-Day SMA
$35.58
-16.6% vs SMA
RSI (14)
62.3
Neutral
Target vs 52W High
$83.97
+92.0% vs high
Next Earnings Report
Nov 10, 2026
3d
until earnings
EPS Est: $-0.58
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |